Fibrosis, Liver
|
0.020 |
Biomarker
|
disease |
BEFREE |
<b>Conclusion:</b> This is the first study to identify the SIRT1/HSF1 pathway as a key therapeutic target for controlling BDL-induced liver fibrosis and to show that SalA confers protection against BDL- and PDGF-BB-induced hepatic fibrosis and ER stress through SIRT1-mediated HSF1 deacetylation.
|
30455644 |
2018 |
Mammary Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
<i>In vitro</i> transfection of PLK1 and HSF1 siRNA into PKL1- and HSF1-positive human breast tumor MDA-MB-231 and human cervical carcinoma HeLa cells inhibited cell growth via suppression of PLK1 and HSF1 mRNA expression, respectively.
|
29067111 |
2017 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
(2007) show that HSF1 is a potent modifier of tumorigenesis and is required for tumor initiation and maintenance in a variety of cancer models.
|
17889643 |
2007 |
Tumor Initiation
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
(2007) show that HSF1 is a potent modifier of tumorigenesis and is required for tumor initiation and maintenance in a variety of cancer models.
|
17889643 |
2007 |
Neoplasms
|
0.400 |
Biomarker
|
group |
BEFREE |
HSF1 blockade-induced tumor thermotolerance abolishment is mediated by JNK-dependent caspase-3 activation.
|
15358168 |
2004 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
HSF1 induces heat shock stress signaling pathway, which might play a role in the carcinogenesis of sporadic colorectal cancer.
|
15457556 |
2004 |
Colorectal Carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
HSF1 induces heat shock stress signaling pathway, which might play a role in the carcinogenesis of sporadic colorectal cancer.
|
15457556 |
2004 |
Malignant neoplasm of colon and/or rectum
|
0.030 |
Biomarker
|
disease |
BEFREE |
HSF1 induces heat shock stress signaling pathway, which might play a role in the carcinogenesis of sporadic colorectal cancer.
|
15457556 |
2004 |
Diabetes Mellitus
|
0.020 |
Biomarker
|
group |
BEFREE |
HSF1/HSP deficiency exists in DM liver which may contribute to hepatic insulin resistance and this deficiency was reflected in lower circulating concentrations.
|
18843550 |
2009 |
Malignant Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
HSF1 bound to LDH-A promoter and the downregulation of HSF1 reduced the expression of LDH-A and subsequently decreased cancer cell glycolysis and growth.
|
19668225 |
2009 |
Primary malignant neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
HSF1 bound to LDH-A promoter and the downregulation of HSF1 reduced the expression of LDH-A and subsequently decreased cancer cell glycolysis and growth.
|
19668225 |
2009 |
Pancreatic carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
HSF1 was downregulated in pancreatic cancer (MIA PaCa-2 and S2-013) and cholangiocarcinoma (KMBC and KMCH) cell lines by HSF1-specific small interfering RNA (siRNA).Nonsilencing siRNA was used as control.
|
21330448 |
2011 |
Malignant neoplasm of pancreas
|
0.040 |
Biomarker
|
disease |
BEFREE |
HSF1 was downregulated in pancreatic cancer (MIA PaCa-2 and S2-013) and cholangiocarcinoma (KMBC and KMCH) cell lines by HSF1-specific small interfering RNA (siRNA).Nonsilencing siRNA was used as control.
|
21330448 |
2011 |
Cholangiocarcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
HSF1 was downregulated in pancreatic cancer (MIA PaCa-2 and S2-013) and cholangiocarcinoma (KMBC and KMCH) cell lines by HSF1-specific small interfering RNA (siRNA).Nonsilencing siRNA was used as control.
|
21330448 |
2011 |
Malignant Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
HSF1 is abundantly expressed in human pancreatobiliary cancer cell lines, as well as in pancreatic cancer tissue, as demonstrated by Western blot and immunohistochemistry, respectively.
|
21330448 |
2011 |
Primary malignant neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
HSF1 is abundantly expressed in human pancreatobiliary cancer cell lines, as well as in pancreatic cancer tissue, as demonstrated by Western blot and immunohistochemistry, respectively.
|
21330448 |
2011 |
Neoplasm Metastasis
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
HSF1 can also function as an inhibitor of transcription and in cooperation with NuRD family factors can repress genes that oppose metastasis.
|
22804234 |
2012 |
Tumor Progression
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
HSF1 (heat-shock factor 1) is the master regulator of the heat-shock response; however, it is also activated by cancer-associated stresses and supports cellular transformation and cancer progression.
|
23510323 |
2013 |
Amyloidosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis.
|
23829269 |
2013 |
melanoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
HSF1 overexpression facilitates the survival of melanoma cells treated with doxorubicin or paclitaxel.
|
24165036 |
2013 |
Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
HSF1 could be also activated by altered kinase signaling characteristic for cancer cells, which is a probable reason for its high activity found in a broad range of tumors.
|
24467529 |
2014 |
Malignant Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Heat shock transcription factor 1 (HSF1), the major regulator of stress response, is frequently activated in cancer and has an apparent role in malignant transformation.
|
25435429 |
2015 |
Primary malignant neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Heat shock transcription factor 1 (HSF1), the major regulator of stress response, is frequently activated in cancer and has an apparent role in malignant transformation.
|
25435429 |
2015 |
Malignant transformation
|
0.050 |
AlteredExpression
|
phenotype |
BEFREE |
Heat shock transcription factor 1 (HSF1), the major regulator of stress response, is frequently activated in cancer and has an apparent role in malignant transformation.
|
25435429 |
2015 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
HSF1 knockout suppresses carcinogen-induced cancer induction in mice.
|
25840992 |
2015 |